Alerts will be sent to your verified email
Verify Email
PHRMASI
|
Phaarmasia
|
Bacil Pharma
|
Shelter Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-9.08 % | -69.0 % | 18.24 % |
|
5yr average Equity Multiplier
|
2.3 | 1.36 | 1.33 |
|
5yr Average Asset Turnover Ratio
|
0.96 | 0.0 | 1.65 |
|
5yr Avg Net Profit Margin
|
-4.04 % | 0.0 | 10.09 % |
|
Price to Book
|
5.59 | 2.24 | 1.45 |
|
P/E
|
77.09 | 93.52 | 8.53 |
|
5yr Avg Cash Conversion Cycle
|
-236.72 Days | 0.0 | 138.55 Days |
|
Inventory Days
|
79.69 Days | 0.0 | 71.81 Days |
|
Days Receivable
|
83.55 Days | 0.0 | 66.01 Days |
|
Days Payable
|
340.86 Days | 0.0 | 6.41 Days |
|
5yr Average Interest Coverage Ratio
|
-92.68 | -943.72 | 84.13 |
|
5yr Avg ROCE
|
-8.87 % | -75.56 % | 25.47 % |
|
5yr Avg Operating Profit Margin
|
-5.39 % | 0.0 | 14.81 % |
|
5 yr average Debt to Equity
|
0.0 | 0.05 | 0.03 |
|
5yr CAGR Net Profit
|
n/a | n/a | 182.84 % |
|
5yr Average Return on Assets
|
-3.86 % | -70.2 % | 13.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.51 % | 0.08 % | 52.32 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -42.59 % | -4.57 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Phaarmasia
|
Bacil Pharma
|
Shelter Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|